BSEOthers8 Aug 2026 · 8 Aug 2026, 08:25 pm

This is to inform you, pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the Board of Directors ....

Kwality Pharmaceuticals Ltd · 539997

✦ AI SummaryMgmt Change

Kwality Pharmaceuticals Ltd has announced the outcome of its Board Meeting, including the re-appointment of Mr. Aditya Arora as Whole Time Director for a further period of five years, the regularization of Mr. Swanith Kapoor as an Independent Director, and the appointment of M/s Verma Khushwinder & Co. as Cost Auditors for the financial year 2026-27.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Kwality Pharmaceuticals Ltd - 539997 - Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGM

Attachments (1)

📄

a76141a9-a3e0-4f71-aabf-6a9263c98094.pdf

pdf

Download →
View document text
Date: August 08, 2026 The Department of Corporate Services BSE Limited Phiroze Jeejeebhoy Towers 25th Floor, Dalal Street, Mumbai- 400001 Company Scrip Code: 539997 Subject: Outcome of Board Meeting Held on August 08, 2026 Dear Sir/Madam, This is to inform you, pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the Board of Directors of the Company, at its meeting held today, i.e., Saturday, August 08, 2026, inter alia, has taken the following decisions:- 1. The Board of Directors of the Company have considered and approved the Report of Board of Directors for the financial year ended as on March 31, 2026 under section 134 of the Companies Act, 2013. 2. The Board of Directors of the Company have considered and approved the Notice of 43rd Annual General Meeting of the Company. 3. The Board has approved the day, date, time and calendar of events and Notice of 43rd Annual General Meeting of the company to be held on 31st August, 2026 at 12:00 noon, through Video Conferencing (‘VC’)/Other Audio Visual Means (‘OAVM’) 4. The Company as required under Regulation 44 of SEBI (LODR) Regulations, 2015, is providing electronic voting (e-voting) facility to the members through electronic voting platform of NSDL. Members holding share either in physical or demat mode as on the cut-off date, i.e. 24th August, 2026 may cast their votes electronically on the businesses set out in the Notice of Annual General Meeting. The e-voting shall commence from Friday, 28th August, 2026 at 09:00 A.M. and ends on Sunday, 30th August, 2026 at 5:00 PM. 5. The Board has fixed the date for Book Closure for purpose of 43rd Annual General Meeting of the Company from Tuesday, 25th August 2026 to Monday, 31st August, 2026 (both days inclusive). 6. The Board has approved the proposal to re-appoint Mr. Aditya Arora and Mrs. Anju Arora who are due to retire by rotation under Section 152(6) of the Companies Act, 2013. They are eligible and has agreed to be re-appointed. Their re-appointment will be placed before the shareholders for approval in the upcoming 43rd Annual General Meeting. 7. The Board has approved the proposal for the regularization of Mr. Swanith Kapoor (DIN: 11662482) as an Independent Director of the Company, who was appointed as an Additional Director (Independent) of the Company with effect from 02nd June, 2026 for a term of 5 consecutive years, subject to the approval of the shareholders at the ensuing 43rd Annual General Meeting. 8. Based on the recommendation of Nomination and Remuneration Committee, Board approved the re-appointment of Mr. Aditya Arora (DIN: 07320410), as Whole Time Director for a further period of five (5) consecutive years commencing from 30th September, 2026 till 29th September, 2031, subject to approval of the shareholders of the Company at the ensuing 43rd Annual General Meeting. Further, detailed disclosure as required under Regulation 30 read with Schedule III Part A Para A of the SEBI Listing Regulation and SEBI Master Circular HO/49/14/14(7)2025-FD POD2/I/3762/2026 dated January 30, 2026 is annexed as Annexure ‘A’ 9. Based on the recommendation of the Audit Committee, the Board approved the appointment of M/s Verma Khushwinder & Co. Cost Accountants (FRN: 000469), as the Cost Auditors of the Company for the financial year 2026-27, their remuneration as approved by the Board shall be subject to ratification at the ensuing Annual General Meeting of the Company. Further, detailed disclosure as required under Regulation 30 read with Schedule III Part A Para A of the SEBI Listing Regulation and SEBI Master Circular HO/49/14/14(7)2025-FD POD2/I/3762/2026 dated January 30, 2026 is annexed as Annexure ‘B’. 10. Appointment of Mr. Rishi Mittal as Scrutinizer for conducting e-voting process for 43rd Annual General Meeting of the Company. This is for your information and record and necessary disclosure for disseminating the information on the website of the Stock Exchange. Thanking You, Yours truly, For Kwality Pharmaceuticals Limited Ramesh Kumar Managing Director DIN:00462656 Annexure –A Details as per Regulation 30 read with Schedule III Part A Para A of the SEBI Listing Regulations and SEBI Master Circular HO/49/14/14(7)2025-CFDPOD2/ I/3762/2026 dated January 30, 2026, are as below: 1. Re-appointment of Mr. Aditya Arora (DIN: 07320410) as Whole Time Director of the Company. S.NO PARTICULARS INFORMATION OF SUCH EVENT 1. Reason for change viz. appointment/re- Re-appointment appointment, resignation, removal, death or otherwise. 2. Date of Appointment/Re-appointment Re-appointment of Mr. Aditya Arora (DIN: 07320410), as Whole Time Cessation (as applicable) & term of Director for a further period of five (5) consecutive years from 30th appointment/reappointment; September, 2026 till 29th September, 2031, subject to approval of the shareholders of the Company at the ensuing 43rd Annual General Meeting of the Company. 3. Brief Profile (in case of Mr. Aditya Arora is the Whole Time Director of the Company. He holds Appointment/Re-appointment) a Bachelor’s degree in Commerce from the Delhi University. He has been associated with the Board of the Company since October 2015. He joined the company at a young age, bringing youthful energy and new perspectives, and made significant contributions towards the vision of making the company one of the leading manufacturers of finished pharmaceutical products. He oversees the production, quality assurance and quality control functions across all manufacturing units and regulatory filings of the Company. He is actively driving operational excellence by aligning these functions with evolving industry standards and next -generation requirements. With his dynamic leadership, proactive approach and strong commitment to operational efficiency, he continues to play key role in the Company’s growth and long term success. 4. Disclosure of relationships between Mr. Ajay Kumar Arora- Father Directors Mrs. Geeta Arora- Mother Mr. Ramesh Kumar- Father’s Brother Mrs. Anju Arora- Father Brother’s Wife 5. Information as required pursuant to Mr. Aditya Arora is not debarred from holding the office of Director by BSE Circular with ref. no. virtue of any SEBI order or any such authority. LIST/COMP/14/2018-19 Annexure –B Details as per Regulation 30 read with Schedule III Part A Para A of the SEBI Listing Regulations and SEBI Master Circular HO/49/14/14(7)2025-CFDPOD2/ I/3762/2026 dated January 30, 2026, are as below: 2. Appointment of Cost Auditor of the Company for the Financial Year 2026-27 S.NO PARTICULARS INFORMATION OF SUCH EVENT 1. Reason for change viz. appointment/re- Appointment appointment, resignation, removal, death or otherwise. 2. Date of Appointment/Re-appointment Date of Appointment: August 08, 2026 Cessation (as applicable) & term of appointment / reappointment; Term of appointment: M/s. Verma Khushwinder & Co., Cost Accountants are appointed as Cost Auditors of the Company for the Financial Year 2026-27, their remuneration as approved by the Board shall be subject to ratification at the ensuing Annual General Meeting of the Company. 3. Brief Profile (in case of M/s Verma Khushwinder & Co., Cost Accountants, having Firm Appointment/Re-appointment) Registration No. 000469, is a practicing Cost Accountant firm based in Jalandhar, Punjab. The firm has extensive experience in the field of Cost Audit, maintenance of Cost Records, Costing & MIS, Internal Audit, Stock Audit, GST Audit and Cost Compliance Reporting. The firm has experienced professionals with more than 33 years of collective experience and has served clients across Punjab, Chandigarh, Himachal Pradesh, Uttar Pradesh, Jammu & Kashmir, Haryana and New Delhi. 4. Disclosure of relationships between Not Applicable Directors